Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04332640 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Next Generation Phaco System
A NA study, sponsored by Johnson & Johnson Surgical Vision.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT04332640 is a NA study that has completed, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 79 participants.
The verdict
NCT04332640, a NA study, has completed, sponsored by Johnson & Johnson Surgical Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
This study is a prospective, open-label clinical study of the VERITAS Vision System. The study will be conducted at up to three sites, with minimum 55 eyes and up to 150 eyes to be treated. The investigator or designee will perform the cataract surgery with the VERITAS Vision System on the subjects. The data from the system log files, the questionnaire, the operative report and other medical records will be used to assess the clinical utilization of the VERITAS Vision System.
Interventions
- DEVICE VERITAS Vision System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2021-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04332640
The ClinicalTrials.gov registry entry for NCT04332640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Surgical Vision, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VERITAS Vision System is the first listed.
NCT04332640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04332640 about?
NCT04332640 is a clinical study titled "Clinical Evaluation of the Next Generation Phaco System". This study is a prospective, open-label clinical study of the VERITAS Vision System. The study will be conducted at up to three sites, with minimum 55 eyes and up to 150 eyes to be treated. The investigator or designee will perform the cataract surgery with the VERITAS Vision System on the subjects...
What is the current status of trial NCT04332640?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2020-09-28. Estimated completion is 2021-05-01.
What interventions are being tested in trial NCT04332640?
The interventions under investigation include: VERITAS Vision System (DEVICE).
Who is sponsoring clinical trial NCT04332640?
This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.